Literature DB >> 16051686

Identifying and pursuing research priorities at the National Center for Complementary and Alternative Medicine.

Richard L Nahin1.   

Abstract

As part of its planning process, the National Center for Complementary and Alternative Medicine (NCCAM), a component of the National Institutes of Health, periodically evaluates how well it applies its criteria for setting research priorities. For its most recent evaluation, NCCAM compared funding levels in fiscal years 2000 and 2003 for 18 diseases with a substantial public health burden including Alzheimer's disease, arthritis, back pain, cancer, diabetes, coronary heart disease, HIV/AIDS, migraine, and stroke, with 7 measures of disease burden: 1) prevalence, 2) mortality, 3) years of life lost (YLL), 4) years lost to disability (YLD), 5) disability-adjusted life years (DALY's), 6) direct costs of illness (COI), and 7) total COI. There is an increasing relationship between NCCAM research funding and disease burden over the 4-year study period that reflects funding of specific research initiatives. The strength of the individual correlations varied among measures, with the strongest correlations seen with total COI and the weakest seen with mortality. When applied with its other criteria, measures of disease burden aid identification and matching of NCCAM priorities with levels of support.

Entities:  

Mesh:

Year:  2005        PMID: 16051686     DOI: 10.1096/fj.05-3727LFE

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  5 in total

Review 1.  Pain research in complementary and alternative medicine in Australia: a critical review.

Authors:  Zhen Zheng; Charlie C L Xue
Journal:  J Altern Complement Med       Date:  2012-08-14       Impact factor: 2.579

2.  A comparison of cancer burden and research spending reveals discrepancies in the distribution of research funding.

Authors:  Ashley J R Carter; Cecine N Nguyen
Journal:  BMC Public Health       Date:  2012-07-17       Impact factor: 3.295

3.  NIH disease funding levels and burden of disease.

Authors:  Leslie A Gillum; Christopher Gouveia; E Ray Dorsey; Mark Pletcher; Colin D Mathers; Charles E McCulloch; S Claiborne Johnston
Journal:  PLoS One       Date:  2011-02-24       Impact factor: 3.240

4.  Development of a manualized protocol of massage therapy for clinical trials in osteoarthritis.

Authors:  Ather Ali; Janet Kahn; Lisa Rosenberger; Adam I Perlman
Journal:  Trials       Date:  2012-10-04       Impact factor: 2.279

5.  Using Health Care Utilization and Publication Patterns to Characterize the Research Portfolio and to Plan Future Research Investments.

Authors:  Luba Katz; Rebecca V Fink; Samuel R Bozeman; Barbara J McNeil
Journal:  PLoS One       Date:  2014-12-10       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.